Since 1990 in most Eastern European countries health care systems have been decentralized or are undergoing the processes of decentralization. Increasingly, diabetic patients are no longer treated by diabetologists but by non-specialized physicians. During the same period structured treatment and teaching programmes have been introduced and health care is increasingly influenced by the St. Vincent declaration. To show the effect of these changes on the quality of diabetes care 90 % (n = 244) of all insulin-treated diabetic patients aged 16 to 60 years and living in the city of Jena (100247 inhabitants) were studied in 1994/1995. The results were compared with the baseline examination of 1989/1990 (n = 190). HbAac (HbAlc/mean normal) in IDDM patients under specialized care was similar in 1994/1995 (1.54+0.27, n=47) to 1989/1990 (1.52+0.31, n = 131, p = 0.0018), but higher under non-specialized care (1.71 + 0.38, n = 80,p = 0.0087). In the total group of NIDDM patients there was no significant change in HbAlc (1994HbAlc ( /1995HbAlc ( :1.75 + 0.4, n = 117, vs 1989HbAlc ( /1990:1.78 + 0.4, n = 59,p = 0.67), but with a tendency to higher HbAlc under non-specialized (1.81+0.4, n =79) compared to specialized care (1.66 + 0.39, n = 38, p = 0.06). Incidence of severe hypoglycaemia (IDDM 0.13; NIDDM 0.04), ketoacidosis (0.02; 0.01) and the prevalence of nephropathy (21%; 35 %) and neurogathy (24 %; 38 %) remained unchanged in comparison to 1989/1990, whereas there was an increase in the prevalence of diabetic retinopathy. Specialized care is mandatory for patients with IDDM. [Diabetologia (1997[Diabetologia ( ) 40: 1350[Diabetologia ( -1357 Keywords IDDM, NIDDM, population-based trial, HbAlc, care quality.
Summary
Since 1990 in most Eastern European countries health care systems have been decentralized or are undergoing the processes of decentralization. Increasingly, diabetic patients are no longer treated by diabetologists but by non-specialized physicians. During the same period structured treatment and teaching programmes have been introduced and health care is increasingly influenced by the St. Vincent declaration. To show the effect of these changes on the quality of diabetes care 90 % (n = 244) of all insulin-treated diabetic patients aged 16 to 60 years and living in the city of Jena (100247 inhabitants) were studied in 1994/1995. The results were compared with the baseline examination of 1989/1990 (n = 190) . HbAac (HbAlc/mean normal) in IDDM patients under specialized care was similar in 1994/1995 (1.54+0. 27, n=47) to 1989/1990 (1.52+0.31, n = 131, p = 0.0018), but higher under non-specialized care (1.71 + 0.38, n = 80,p = 0.0087). In the total group of NIDDM patients there was no significant change in HbAlc (1994/1995:1.75 + 0.4, n = 117, vs 1989/1990:1.78 + 0.4, n = 59,p = 0.67), but with a tendency to higher HbAlc under non-specialized (1.81+0.4, n =79) compared to specialized care (1.66 + 0.39, n = 38, p = 0.06). Incidence of severe hypoglycaemia (IDDM 0.13; NIDDM 0.04), ketoacidosis (0.02; 0.01) and the prevalence of nephropathy (21%; 35 %) and neurogathy (24 %; 38 %) remained unchanged in comparison to 1989/1990, whereas there was an increase in the prevalence of diabetic retinopathy. Specialized care is mandatory for patients with IDDM. [Diabetologia (1997) 40: 1350-1357] Keywords IDDM, NIDDM, population-based trial, HbAlc, care quality.
Insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes mellitus confer a high risk of developing diabetic late complications with the result of excess mortality and morbidity [1] [2] [3] [4] [5] . Up to the present, optimal quality of care and regular screening have been the most important factors for preventing late complications [6] [7] [8] [9] [10] . Most of the data available concerning quality management of diabetes have been derived from selected populations [11, 12] .
The purpose of this trial was to prove the implementation of the St.Vincent Declaration [13] in a non-selected population of diabetic patients in Germany with respect to the change in the health care from a centralized state system to a private one.
Subjects and methods
The JEVIN Trial (Jena's St. Vincent Trial), was started in 1989 in Jena (population in 1989:105 825), a town in the former German Democratic Republic [14] . The centralized diabetes care system was at that time intact. It was based on nationwide country and district diabetes care units and a diabetes registry [15] . At 31 December 1989 there were 3923 patients registered in Jena [14] . We examined 83 % (n = 190) of the 229 registered insulin-treated patients in the age group of 16 to 60 years [14, 16] . Since 1990, following the reunification of Germany, the health care system has been decentralized. Diabetes care units were mostly closed and diabetic patients were increasingly treated by non-specialized physicians. The central diabetes registry was discontinued. Ambulatory and inpatient care is sharply demarcated, with specialized physicians restricted from admitting patients without assignment of primary care physicians. Hospital care physicians are largely proscribed from providing outpatient care [17] .
We identified the patients for the 5-year follow-up trial in 1994/1995 from four independent sources: 1) the previous diabetes registry from 1989; 2) the hospital database, because up to 1995 in Thuringia insulin treatment had only been started in hospitals; 3) the database of the university clinic outpatient department and 4) databases of family physicians. This method of using several sources guarantees 100 % identification of the target population by tracking each patient in at least two different sources.
Patients. In 1994/1995, we identified 271 insulin-treated diabetic patients aged 16 to 60 years and living in the city of Jena (population in 1995: 100242). Of these patients (IDDM n = 127, NIDDM n = 117, [18] ) 90 % were examined by a physician. Since 1990 17 insulin-treated registered patients had died. Of the missing 27 patients, 10 refused to take part (3.7 %) and of the rest (n = 16, 6.3 %) we were either unable to trace the address or patients did not reply. The characteristics of the patients examined in 1994/1995 in comparison to 1989/1990 are shown in Table 1 .
Intervention since 1989/1990 . Following the reunification of Germany, with the change of the political system, there have been great shifts in socioeconomic factors. For example materials for blood glucose self-monitoring and insulin pens became available to everyone at all times. Additionally, the 'diabetic diet' [19, 20] has been liberalized [21] .
Following the recommendations of the St. Vincent Declaration [13] , structured treatment programmes for both IDDM and NIDDM were established [22] [23] [24] [25] [26] [27] [28] [29] . Since 1989/1990 73 % of IDDM (n = 93) and 34 % of NIDDM patients (n = 40) have taken part in a 5-day structured diabetes treatment and teaching programme (5-DTTP) for intensified conventional insulin therapy [22] . Of the NIDDM patients 63 % (n = 74) have taken part in a 5-DTTP for type 2 diabetic patients with insulin therapy [23] . A total of 9 % (n = 10) of NIDDM patients took part in both 5-DTTPs [22, 23] . Only 27 % (n --34) of IDDM patients and 11% (n = 13) of NIDDM patients have not taken part in a Dq-TP up to the present. Until 1993, in the area of Jena, 56 % of general practitioners and physicians for internal medicine [16] took part in postgraduate training courses for the treatment of NIDDM.
Assessment of quality of care.
To assess the quality of care the following investigations were performed: measurement of haemoglobin Aac (HbAac, HPLC, Diamat, normal range: 4.4-5.9 % in 1994/1995, 3.1-5.2 % in 1989/1990, laboratory tests in 1989/1990 were performed in Aberdeen, the normal range of each method was assessed measuring 100 healthy subjects). For comparison of the two HbAlc methods values were normed on the mean normal value (original HbAlc value divided by the mean normal of the method), a method which guarantees good reliability as shown in the German Working Group for structured diabetes care. Self-monitoring and insulin dose adjustment were registered as frequency of tests/adjustments per week. The incidence of acute complications (severe hypoglycaemia, i.e. need for glucose or glucagon injection, ketoacidosis with hospitalization) were assessed by interview and controlled by comparison with emergency protocols and hospital records. Investigation of long-term diabetic complications was done by: 1) funduscopy through dilated pupils by an ophthalmologist. Retinopathy was staged as follows: normal, stage 1 (microaneurysms or soft exudates only), stage 2 (blot haemorrhages, hard exudates), stage 3 (proliferation and vitreous haemorrhages) [30] . 2) Screening for peripheral polyneuropathy according to Young et al. [4] . 3) Screening for nephropathy by measuring the urine albumin concentration (immunoturbidimetry 1989/1990, nephelometry 1994/1995, normal range: < 20 mg/1). For calculation the mean of three early morning urine tests within a period of 3 to 6 weeks was used. In the case of only two specimens being available the results were used only if both were in the normal range or both were elevated. Infected urine specimens (bacterial counts > 105/ml) were excluded.
Height and body weight were assessed with the patients wearing light clothing and without shoes. Blood pressure in the sitting position was measured after the patient had rested for 10 min by using a standard sphygmomanometer according to World Health Organisation (WHO) recommendations. Further socioeconomic data, quality of life and treatment satisfaction were assessed, and will be published in a forthcoming paper.
Statistical analysis was performed using Statgraph. All data are presented as mean _+ SD. For comparisons the Student's t-test, IDDM and NIDDM patients. Eighty-five percent (n = 108) of IDDM and 48 % (n = 56) of NIDDM patients performed insulin therapy with short-acting and mixed/NPH-insulin with mostly 4 to 6 injections per day.
In IDDM patients there were no correlations between HbAlc and age (r = -0.04, p --0.66), diabetes duration (r = 0.07, p = 0.47), insulin dosage/kg body weight (r --0.18, p = 0.07) or the number of insulin injections/day (r = 0.09, p = 0.33). But we found a positive correlation between systolic blood pressure and HbAlc (r = 0.2, p = 0.036) and a negative correlation between HbAI~ and body mass index (r =-0.26, p = 0.0062) and HbAlc and participation in a 5-DTTP for intensified conventional insulin therapy [22] (r = -0.22, r = 0.023).
Similar results were found for NIDDM patients: a negative correlation between HbAI~ and body mass index (r = -0.34, p = 0.0065) and HbAI~ and participation in a 5-DTTP for type 2 diabetic patients with [4] , b abnormal age-related score according to Liniger et al. [30] ; mean at both sides, c on at least one side insulin therapy [23] and between the frequency of blood glucose monitoring (r --0.28, p = 0.03).
Acute diabetic complications. The incidence of acute complications, severe hypoglycaemia and ketoacidosis, remained stable in 1989/1990 compared to 1994/ 1995 as shown in Table 3 .
Retinopathy. In 1994/1995 funduscopy was performed in 76 % of IDDM and in 68 % of NIDDM patients. The prevalence of retinopathy increased in IDDM and NIDDM (Tabl e 4). Blindness (visus < 0.02) was found in three patients in !994/1995 (IDDM n = 1, NIDDM n = 2), whereas there was one blind patient identified in 1989/1990. Neuropathy. According to the neuropathy disability and symptom score used for diagnosis of peripheral neuropathy [4] in 1994/1995 peripheral neuropathy was found in 24 % of IDDM and 38 % of NIDDM patients. The prevalence of impaired vibration perception (age-related score according to Liniger et al. [31] at the first metatarsal bone) remained unchanged (Table 4) .
Nephropathy. There was no significant change in the prevalence of nephropathy, either in albuminuria or in serum creatinine (Table 4) . In IDDM patients early renal failure was found in four patients after a mean duration of diabetes of 26.3+ 11.2 (range 8-37) years. Two patients had received a renal transplant.
In IDDM patient s a positive correlation was found between albuminuria and duration of diabetes (r = 0.3, p = 0.0015) and serum creatinine (r = 0.55, p < 0.001) arid between systolic blood pressure and albuminuria (r = 0.19, p = 0.04). In NIDDM patients there was a positive correlation between albuminuria and serum creatinine (r = 0.26, p = 0.04), but there were no correlations between age and duration of diabetes or blood pressure.
Smoking. The number of current smokers in IDDM patients decreased significantly from 43 % in 1989/ 1990 to 32% in 1994/1995 (p=0,0005) and in NIDDM from 32 % to 24 % (p < 0.00001).
Multivariate analysis. Performing multivariate analysis for IDDM patients, the most important factor associated with HbAI~ (R squared 0.053) was regular treatment by a diabetologist (c =-0.17, p = 0.009). All other parameters, investigated in the model (sex, age and duration of diabetes, BMI, frequency of insulin injections/day, frequency of self-monitoring, insulin dosage and educational level) had no statistically significant associations with HbA~.
The most important parameters associated with HbA~c in NIDDM patients (R squared 0.15) were the frequency of blood glucose self-tests/week (c =-0.013, p = 0.003) and the daily insulin dosage (c = 0.48, p = 0.01). No associations were found for age, BMI, treatment by specialized physicians, diabetes duration, frequency of insulin injections, urine glucose self tests/week and educational level.
Discussion
Both IDDM and NIDDM are common diseases associated with reduced life expectancy and high mortality and morbidity [1, 2, 32, 33] . The most important factors for preventing late complications are better quality of diabetes care with near normoglycaemia, and regular screening of patients [6, 7, 10] . However, to evaluate the efficacy of centralized diabetes care in 1989/1990 we chose a selection-free population of insulin-treated diabetic patients aged 16 to 60 years. Older patients were not studied because diabetes is only one facet of their multimorbidity. In these patients HbAlc is not the primary parameter to estimate care quality. For these patients individualized treatment goals are crucially important. Younger patients are mostly in employment and the goal of the therapy is near normoglycaemia to prevent late complications [34] .
In 1989/1990 under a centralized diabetes care system [14, 15, 35, 36] all diabetic patients were registered and regularly examined at regional diabetes care centres. Looking at HbA~c in insulin-treated IDDM and NIDDM patients aged 16 to 60years, quality of diabetes care appeared to have been successfully achieved. Regional diabetes care centres existed overall in the former GDR and everywhere patients were treated following the same guidelines. Although results from other East European countries showed very high HbAI~ levels before intervention [37] quality of diabetes care in Jena seems to be representative of the whole GDR [36] . But in 1994/ 1995, at the time this follow-up trial was performed, this centralized diabetes care system no longer existed. Most patients are now treated by GPs, and about 19 % by diabetologists [16] . Up to the present no data derived from non-selected populations have been available to measure influences of the shift from centralized to private health care systems. Based on the rationale that an accurate estimation of the diabetes prevalence can be assessed only by using more than one source for identification of diabetic patients [38, 39] , in the present trial three independent sources were used to prevent a bias due to patient selection.
In IDDM patients under specialized care the HbAlc was similar compared to the population studied in 1989/1990. But it was higher for IDDM patients treated by non-specialized physicians only. There was no positive selection of patients under specialized care regarding socioeconomic factors and the prevalence of late complications. In the multivariate analysis we found only one parameter independently associated with HbAlc: care by a diabetologist.
In NIDDM patients we found no significant difference in HbAlc in patients under specialized or nonspecialized care. But, more than half of general practitioners and physicians for internal medicine [16] took part in postgraduate training courses for NIDDM patients [40] . This may be one of the reasons for the stability of treatment quality in NIDDM patients. There was an impressive increase in regular blood glucose self-monitoring from 1989/1990 to 1994/1995 in IDDM (from 56 to 93%) and in NIDDM (from 24 to 87 %). However, in the multivariate analysis the frequency of blood glucose monitoring was the most independent factor associated with HbAlc in insulin-treated NIDDM patients only. Perhaps this is a further reason why impairment of HbA~c was prevented in NIDDM patients, whereas in older NIDDM patients no benefit of blood glucose self-monitoring has been reported [41] . Another issue concerns the question of whether insulin monotherapy is really superior to combination therapy with insulin and oral antidiabetic drugs. Regarding the disappearance of deterioration of HbAI~ after withdrawal of most of the sulfonylureas in the NIDDM population studied, this issue might be negotiated. In the UKPDS [8, 9] , up to now no advantages of therapies with oral antidiabetic drugs have been seen. In numerous trials the efficacy of DTTP [22, 23, 29] for both IDDM and NIDDM patients, with or without insulin treatment, has been established. The quality of diabetes care improved, the incidence of acute complications and frequency and duration of patients' hospitalization could be reduced or were stable [24] [25] [26] [27] [42] [43] [44] [45] . Following these results, training and teaching in diabetes management and care for people of all ages with both IDDM and NIDDM and for their families was one of the central recommendations of the St.Vincent Declaration action programme, and also of other national and international guidelines for treatment of diabetic subjects [18, 28, [46] [47] [48] [49] .
Although in several trials for selected patients, educated at our centre, significant improvement of quality of diabetes care after participation in 5-DTTP was established [26, 27, [50] [51] [52] no significant improvement in quality of diabetes care in the selection-free population of diabetic patients could be found. On the other hand, after the discontinuation of the centralized health care system, an impairment in quality of diabetes care was shown in IDDM patients without specialized care, but there was no increase in the incidence of ketoacidoses as was expected [53] . Together with the disappearance of the centralized diabetes care system there were great changes in individual lifestyles which may interact with patients' quality of diabetes care: for example need for more flexibility, the availability of different foods, new opportunities to travel and a higher unemployment rate.
The prevalence of neuropathy and microalbuminuria were similar to 1989/1990 and have been reported by other groups [3] [4] [5] [54] [55] [56] [57] [58] [59] . Fortunately the number of smokers decreased in our study, despite a tremendous increase in cigarette advertisements. Perhaps the lower frequency of smokers in 1994/1995 versus 1989/1990 in IDDM and NIDDM led to a reduction of overt nephropathy. Numerous trials clearly demonstrated that cigarette smoking appears to be a strong risk factor for the development and progression of nephropathy in diabetic patients [60, 61] .
However, regarding retinopathy there was a significant increase in frequency in 1994/1995 compared to 1989/1990 in both IDDM and NIDDM, including a bias resulting from missing up to a quarter of eye examinations in 1994/1995. Concerning this tendency and the increase of HbAlc in IDDM patients without specialized care, modifications of the present private health care system are mandatory to prevent inconvenient and costly treatment of diabetes complications in the future.
In particular regarding the changes in health care systems in other Eastern European countries, the results of the present non-selected, population-based trial are important. Models like the St.Vincent Declaration action programme or the WHO Partnerships for Health, aiming at the improvement of long-term outcome of patients and helping them to improve self-management, should be emphasized, but must be also critically monitored and evaluated. In all in-and outpatient centres for diabetes care it must be mandatory to take pfirt in a regular system of quality assurance [62, 63] as shown by the Working Group of structured diabetes therapy of the German Diabetes Association [45] . However, only a prospective controlled trial could fully answer the question of whether IDDM patients who continue to look for specialized care will have a better outcome.
